SomaLogic Publishes Details of Upcoming Lung Cancer Test, New Proteomics Discovery Platform

The two studies, published in Nature Precedings, are part of an effort by the Boulder, Colo.-based firm to gain more attention for the role its technology platform can play in diagnostics development.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.